CVS Group (LON:CVSG) Announces Quarterly Earnings Results

CVS Group (LON:CVSG) announced its quarterly earnings data on Thursday. The company reported GBX 85.60 earnings per share (EPS) for the quarter, Digital Look Earnings reports. CVS Group had a return on equity of 5.35% and a net margin of 2.31%.

Here are the key takeaways from CVS Group’s conference call:

• Revenue rose 5.9% to £712.8 million and adjusted EBITDA increased 5.1% to £141.5 million, with the margin maintained at 19.9% despite inflationary pressures. Adjusted EPS grew 6.9% to 85.6 pence.
• Like-for-like revenue growth was 2.1%, below the company’s 4%–8% target, as weaker U.K. consumer confidence and unusually hot weather reduced routine appointments and delayed procedures. Management said trading has since returned to pre-heatwave levels and expects to perform in line with market expectations.
• CVS completed a refinancing that provides £350 million of committed facilities through May 2030 on improved terms, while leverage remained below its 2.0x threshold at 1.63x. The company is also progressing with a £50 million share buyback expected to finish within the next couple of months.
• Australia remains a key expansion opportunity, contributing about £20 million of EBITDA excluding central costs, with further Australian and U.K. acquisitions signed or completed since year-end. Management expects to invest around £50 million annually in acquisitions while remaining selective on valuation.
• Organic growth initiatives include the Healthy Pet Club Advanced subscription, which had attracted approximately 14,500 clients shortly after launch, alongside digital booking, CRM, AI consultation tools, and improved client communications. Capital expenditure is expected to moderate to about £30 million annually, potentially freeing cash for acquisitions or shareholder returns.

CVS Group Price Performance

Shares of CVS Group stock traded down GBX 83 during trading on Thursday, hitting GBX 1,219. 384,143 shares of the stock traded hands, compared to its average volume of 879,933. The firm’s fifty day moving average is GBX 1,289.88 and its 200-day moving average is GBX 1,230. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34. CVS Group has a 52 week low of GBX 1,062 and a 52 week high of GBX 1,648. The stock has a market cap of £828.55 million, a price-to-earnings ratio of 17.69, a PEG ratio of 1.77 and a beta of 1.07.

Wall Street Analysts Forecast Growth

CVSG has been the topic of a number of analyst reports. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a report on Thursday. Jefferies Financial Group raised their target price on CVS Group from GBX 1,350 to GBX 1,400 and gave the stock a “hold” rating in a research note on Friday, July 31st. Shore Capital Group reiterated a “hold” rating and set a GBX 1,400 price target on shares of CVS Group in a research report on Thursday. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 1,700 price objective on shares of CVS Group in a research report on Monday, July 27th. Four research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, CVS Group presently has an average rating of “Moderate Buy” and an average target price of GBX 1,666.67.

Insider Buying and Selling at CVS Group

In other CVS Group news, insider Joanne Shaw acquired 1,592 shares of the business’s stock in a transaction on Monday, August 10th. The shares were acquired at an average price of GBX 1,287 per share, for a total transaction of £20,489.04. Also, insider Robin Alfonso bought 768 shares of the stock in a transaction dated Thursday, August 6th. The shares were acquired at an average price of GBX 1,294 per share, with a total value of £9,937.92. Over the last quarter, insiders have bought 3,860 shares of company stock worth $4,956,696. 1.48% of the stock is currently owned by company insiders.

About CVS Group

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.